SAN FRANCISCO and LAGUNA, Philippines, November 4 /PRNewswire/ --

Validus Technologies Corporation and Integrated Microelectronics, Inc. are pleased to announce a strategic manufacturing alliance serving the global powered card industry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081104/AQTU067LOGO)

Validus and IMI today announced that they have entered into a comprehensive manufacturing agreement to serve the powered card industry. The first powered card product version, of many to come, designed by Validus and manufactured by IMI is the VALIDcard(TM). The VALIDcard(TM) is the world's first powered card offering fully self-contained biometric authentication within a card form factor.

HSIN-CHU, Taiwan, November 4 /PRNewswire/ --

- Greener display driver ICs anticipated

TSMC (TSE: 2330, NYSE: TSM) has enhanced its 0.13um process technology with immediate availability of a 1.5/6/32V technology, targeted at high resolution mobile handset display drivers.

The high-yield process features an Aluminum Copper (AlCu) backend metal scheme and is designed to meet energy reduction targets, while responding to the market's demand for smaller line width options, reducing die size in next-generation high-resolution display driver ICs.

Aristotle figured out pretty early on that human beings are by their nature constantly pulled by two opposing forces: on the one hand their propensity to go after immediate rewards, even though they are often deleterious for them (akrasia, or “weakness of the will”); on the other hand the necessity to work for their long term welfare (eudaemonia, loosely translated as “happiness” but better understood as flourishing).

We all know that high cholesterol is associated with the possibility of diabetes, but what about a connection between triglyceride levels and obesity? It may seem far fetched, but conducting a simple test of bodily triglyceride levels may give beneficial insight to those of who that are more susceptible for becoming obese.

Awww. Isn't this squirrel just so cute? You might think that now, but stare long enough at the beady eye of this Eastern Fox Squirrel (Family Sciuridae : Sciurus niger Linnaeus), and you'll see that it's actually a reproducing nightmare overrunning a campus or orchard near you. In fact, the Eastern Fox Squirrel is reproducing so quickly that researchers at the University of California Davis are putting them on birth control.

LONDON, November 4 /PRNewswire/ --

- Pension Corporation Launches Pensions Tomorrow Initiative With London School of Economics and Political Science

Pension Corporation, a leading provider and underwriter of pension solutions, yesterday launched Pensions Tomorrow, a new initiative in association with the Department of Management at the London School of Economics and Political Science (LSE).

The Pensions Tomorrow initiative aims to bring together industry leaders, government, regulators and think-tanks to debate the growing issues of pensions and longevity in an independent forum. It will produce high-quality and timely commentary for a broad audience, and independent peer-reviewed research on the major issues facing pensions.

LONDON, November 4 /PRNewswire/ --

Planalytics Inc., the global leader in Business Weather Intelligence(R), explained in its October WeatherCall(SM) report that the month was generally typical in terms of breezy and cool conditions. However, inconsistent temperatures and precipitation patterns kept retailers guessing throughout the month. Footwear companies seemed to benefit the most overall, selling items such as boots.

The biggest story of the month was the wintry finale, as snow fell in some parts of England and Wales. This was the first October snowfall in the southeast since 1974 and for central London, since 1934. This caused a large run up in sales for outerwear and cold weather accessories.

WASHINGTON, November 4 /PRNewswire/ --

FairWinds Partners, LLC, has been working with Verizon Communications to develop and implement an innovative approach to optimizing Verizon's domain portfolio. This new approach has enabled Verizon not only to better provide its customers with more relevant online experiences that deliver desired content, but also to do so in a more cost-effective manner.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070810/NEF018 )

CALGARY, Canada, November 4 /PRNewswire/ -- Oncolytics Biotech Inc. (Oncolytics) (TSX:ONC, NASDAQ:ONCY) announced today that it has made a decision to pursue a pivotal (Phase II/III) randomized trial using the combination of REOLYSIN(R) with paclitaxel/carboplatin in refractory patients with head and neck cancers. The decision was made following a review of results by the Company's Board of Directors from the Company's ongoing U.K. Phase I and Phase II combination REOLYSIN(R) and paclitaxel/carboplatin clinical trials. The results were presented November 1, 2008 at the International Society for Biological Therapy of Cancer (iSBTc) annual meeting in San Diego, CA.